Markets rallied strongly, with Vedanta considering a second interim dividend. LIC launched a policy revival campaign, while GMR Airports an...

Vedanta Chairman Anil Agarwal reaffirmed the company's commitment to unlocking value, saying the four new companies that will emerge from t...

LIC share price: State-owned LIC's shares rose 2.4% on news of a potential 50% stake acquisition in ManipalCigna Health Insurance. This mov...

LIC plans to buy half of ManipalCigna Health Insurance. The deal could be worth ₹4,000 crore. This move will let LIC enter the health insur...

Shares of Hyundai, Nykaa, General Insurance, Zydus, BSE will be in focus as the companies will announce their second quarter results today.

LIC is considering entering the health insurance sector, as reported by Times of India, quoting LIC chairman Siddhartha Mohanty. Mohanty st...

HDFC Bank received approval from the Reserve Bank to sell its 90% stake in the education loan company HDFC Credila- a move that will boost ...

The divestment process of IDBI Bank will complete in the fiscal year 2023-24, Department of Investment and Public Asset Management (DIPAM) ...

Paytm’s trading debut in November turned out to be the worst for any major technology stock since the dot-com bubble era of the late 1990s.

“We are pleased to inform you that the Bank has received an intimation from the RBI on December 9, 2021, that it has granted its approval t...

This comes at a time when in the month of September, Bloomberg news channel said that Vedanta has started approaching potential investors f...

The fund infusion exercise will help raise the capital adequacy ratio of the lender.

The stock fell 7.19 per cent to hit a low of Rs 52.25 on the BSE early on Friday.

The acquisition will help LIC, the only big insurer in the country without a bank, to spread its wings.

Mergers of private banks do not come to Finance Ministry, rather it is for the regulator to see, said an official.

Fund managers feel that with the Indian telecom market showing signs of saturation, the swap deal will be critical for the co's next phase ...

As a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...